WHO gaat toch weer verder met hydroxychloroquine testen, nadat The Lancet eigen publicatie bekritiseerde.
3 June 2020
22:30
“On May 25, the WHO announced it had temporarily suspended the trials to conduct a safety review.
The UN health agency’s decision came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among Covid-19 patients.
“On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.
“The executive group received this recommendation and endorsed continuation of all arms of the Solidarity Trial, including hydroxychloroquine.
More than 3,500 patients have been recruited across 35 countries to take part in the trials.”
